Relation
Restructuring Structural Heart Disease Practice During the COVID-19 Pandemic
- This paper discusses development of a new schema more management and treatment for patients with structural heart disease (SHD) during the era of COVID-19
- The paper describes how patients with SHD may be at higher risk of infection and higher risk of poor outcome if infected with COVID-19 due to the nature of SHD itself as well as the possibility for patients with SHD to be comorbid with other diseases
- This paper goes on to detail a few different sections of information including how physicians who treat patients with SHD should transition toward telehealth, how specific SHD appointments should be rescheduled and reprioritized based off current condition, patient selection based off condition, the minimization of risk and optimization of SHD related procedures, as well as they eventual transition back to pre-COVID-19 era treatment of patients with SHD
0
1
Updated 2020-12-17
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Learn After
Transition Toward Telehealth by Physicians who Treat SHD
Rescheduling and Reprioritizing Patient Visits Based Off Current Condition and Relative Patient Risk
Patient Selection Based off Condition and Environmental Restraints
Minimizing Risk and Optimizing Procedures for SHD During the COVID-19 Era
The Distant and Staged Transition Back to Pre-COVID-19 Era Practices